Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Over the past decade, the management of Fuchs' endothelial corneal dystrophy (FECD) and pseudophakic bullous keratopathy (PBK) has been revolutionized by the development of posterior lamellar keratoplasty techniques: DSAEK and DMEK.
DSAEK (Descemet Stripping Automated Endothelial Keratoplasty) involves replacing the patient's endothelium and pathological descemetum with a descemetic endothelial graft combined with a thin stromal lamella. The endothelial density of the grafts is generally greater than 2,400 cells/mm². Depending on the grafting center and tissue bank, grafts may be either pre-cut in the tissue bank or cut on the operating table by the surgeon himself.
The donor graft is placed on an artificial anterior chamber, and automated microkeratome cutting produces grafts with an average thickness of 100 to 200µm, sometimes less than 100um (known as UT-DSAEK or ultra-thin DSAEK).
DMEK (Descemet Membrane Endothelial Keratoplasty) is a strictly endothelium and Descemet's membrane graft, as close as possible to the original anatomy of the cornea. The graft is dissected manually either in a tissue bank (pre-cut grafts) or on the operating table by the surgeon. The thickness of the graft is between 15 and 18 microns.
The primary objective of this observational cohort is to compare the evolution of visual acuity after DMEK, DSAEK or UT-DSAEK transplantation.
Secondary objectives are to compare the evolution of endothelial cell density, corneal thickness and early and late post-operative complications, and to identify factors predictive of these different endpoints.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| DMEK | Patients who received Descemet Membrane Endothelial Keratoplasty |
| |
| DSAEK | Patients who received Descemet Stripping Automated Endothelial Keratoplasty with preoperative graft thicker than 160 µm |
| |
| UT-DSAEK | DSAEK: patients who received Descemet Stripping Automated Endothelial Keratoplasty with preoperative graft thinner than 160 µm |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| visual acuity comparaison | Procedure | Data collection |
|
| Measure | Description | Time Frame |
|---|---|---|
| BSCVA | best spectacle-corrected visual acuity (logMAR) | at 1 year after surgery, but also at day 8, day 15, 1 month, 3 months, 6 months and every year up to 10 years after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| ECD | endothelial cell count (cells/mm²) | at 1 month, 3 months, 6 months and every year up to 10 years after surgery |
| CCT | central cornea thickness (µm) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
patients who received a posterior lamellar keratoplasty
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Arpiné EL NAR, PhD | Contact | 0033387557766 | projet-recherche-clinique@chr-metz-thionville.fr |
| Name | Affiliation | Role |
|---|---|---|
| Jean-Marc PERONE, MD | CHR Metz Thionville Hopital de Mercy | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHR Metz-Thionville Hopital de Mercy | Recruiting | Metz | 57085 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41921039 | Derived | Delean S, Goetz C, Zevering Y, Perone JM. Central Corneal Thickness 6 Postoperative Months After Pseudophakic-Descemet Membrane Endothelial Keratoplasty, Triple-Descemet Membrane Endothelial Keratoplasty, and Cataract Surgery Alone: A Retrospective Cohort Study and Literature Review. Cornea. 2026 Mar 11. doi: 10.1097/ICO.0000000000004144. Online ahead of print. |
Not provided
Not provided
No
According to French law and the French Data Protection Authority (CNIL), the investigators will not be able to publicly share individual participant data; however, the investigators plan to share the conclusions through peer-reviewed publications and conferences.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005642 | Fuchs' Endothelial Dystrophy |
| D003316 | Corneal Diseases |
| ID | Term |
|---|---|
| D003317 | Corneal Dystrophies, Hereditary |
| D005128 | Eye Diseases |
| D015785 | Eye Diseases, Hereditary |
| D030342 | Genetic Diseases, Inborn |
Not provided
Not provided
Not provided
Not provided
Not provided
| at 1 month, 3 months, 6 months and every year up to 10 years after surgery |
| post-operative complication | graft reject (yes/no), graft detachment (yes/no), graft failure (yes/no), eye infection (yes/no) | up to 10 years after surgery |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |